By Investing.com
Publication Date: 2025-11-28 01:44:00
Oracle Corporation (NYSE:) is at a critical point. Its shares are down about 40% from recent highs, while analysts remain deeply divided on future developments. The enterprise software giant’s massive investment in AI infrastructure, particularly its controversial $300 billion OpenAI contract, has sparked heated debate about whether the current price represents a compelling buying opportunity or a value trap.
With the stock trading at around $205 and carrying a high P/E ratio of 47, investors will have to deal with conflicting signals from Wall Street analysts and growing concerns about the company’s aggressive investment plans.
Analyst targets rise from $175 to $430 as OpenAI threat raises concerns
The analyst community remains wildly divided on Oracle’s prospects. Price targets range from a conservative $175 to an ambitious $430. Deutsche Bank remains bullish and maintains its Buy rating with a target of $375. She argues that the market Oracle…
